Welcome

The Stephen Sanig Research Institute is an independent, non-profit, scientific research organisation.  Established in 2005, the Institute commemorates the memory of Stephen Sanig, who tragically died of meningococcal septicaemia at the age of seven.

Based at the Australian Technology Park, the Institute's mandate is to contribute to improved health outcomes by developing and disseminating new and effective methods of prevention, treatment and management of medical conditions such as:

• Infectious diseases (in particular, meningococcal disease and associated septicaemia);

• Cancers (with particular focus on solid tumours, breast cancer, and colon cancer);

• Inflammatory and auto-immune diseases such as rheumatoid arthritis and Crohn’s disease.

With a firm commitment to improving health outcomes for patients, and realising that such outcomes are only achievable when laboratory science is coupled with clinical medicine, the Institute continually innovates in the search for technologies enabling the development of novel biopharmaceutical drug candidates from research to manufacture.  At the same time not forgetting existing drug candidates, the Institute continues to investigate methods for making them safer and more efficacious.

The Institute is committed to a collaborative approach, and is actively pursuing partnerships with leading research institutions both in Australia and internationally.

The Institute’s research program is deliberately interdisciplinary, aiming at integrating novel insights from diverse scientific fields such as cell biology, immunology, biophysics, biochemistry and biotechnology.  The Institute’s founders expect the Institute to serve as a catalyst – pioneering new research ideas, attracting talented students to careers in scientific research, and contributing to the professional development of researchers and medical practitioners working in the field.